Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,169 | -61,083 | -36,330 | -14,911 | -32,968 |
| Depreciation Amortization | 188 | 143 | 95 | 47 | 156 |
| Other Working Capital | 1,020 | 6,862 | 6,526 | 1,931 | 2,569 |
| Other Operating Activity | 14,611 | 8,000 | 2,732 | 776 | 3,142 |
| Operating Cash Flow | $-66,350 | $-46,078 | $-26,977 | $-12,157 | $-27,101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -316 | -46 | -51 | -16 | -870 |
| Investing Cash Flow | $-316 | $-46 | $-51 | $-16 | $-870 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 256,383 | 256,150 | 69,121 | 68,850 | 17,832 |
| Other Financing Activity | -9,024 | -9,024 | -9,024 | -9,024 | 0 |
| Financing Cash Flow | $247,359 | $247,126 | $60,097 | $59,826 | $17,832 |
| Beginning Cash Position | 32,426 | 32,426 | 32,426 | 32,426 | 42,565 |
| End Cash Position | 213,119 | 233,428 | 65,495 | 80,079 | 32,426 |
| Net Cash Flow | $180,693 | $201,002 | $33,069 | $47,653 | $-10,139 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,350 | -46,078 | -26,977 | -12,157 | -27,101 |
| Capital Expenditure | -316 | -46 | -51 | -16 | -870 |
| Free Cash Flow | -66,666 | -46,124 | -27,028 | -12,173 | -27,971 |